Anterogen.Co.,Ltd. (065660.KQ)
KRW 16060.0
(-6.3%)
KRW 16060.0
(-6.3%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -291.93 KRW | 58.64% |
| 2022 | -705.88 KRW | -1087.35% |
| 2021 | -59.45 KRW | 87.64% |
| 2020 | -481.12 KRW | -2.37% |
| 2019 | -469.96 KRW | -312.25% |
| 2018 | -114.00 KRW | -300.0% |
| 2017 | 57.00 KRW | 14.0% |
| 2016 | 50.00 KRW | 655.56% |
| 2015 | -9.00 KRW | 95.87% |
| 2014 | -218.00 KRW | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -53.23 KRW | 9.35% |
| 2024 Q1 | -58.72 KRW | -199.74% |
| 2023 Q4 | -19.59 KRW | 81.56% |
| 2023 Q3 | -106.24 KRW | 37.48% |
| 2023 Q2 | -169.93 KRW | -4525.26% |
| 2023 FY | - KRW | 58.64% |
| 2023 Q1 | 3.84 KRW | 106.46% |
| 2022 Q2 | -220.18 KRW | -86.59% |
| 2022 Q1 | -118.00 KRW | -475.61% |
| 2022 Q4 | -59.41 KRW | 61.69% |
| 2022 Q3 | -155.06 KRW | 29.58% |
| 2022 FY | - KRW | -1087.35% |
| 2021 Q3 | -43.00 KRW | -114.05% |
| 2021 Q2 | 306.00 KRW | 198.71% |
| 2021 Q4 | -20.50 KRW | 52.33% |
| 2021 FY | - KRW | 87.64% |
| 2021 Q1 | -310.00 KRW | 0.0% |
| 2020 Q4 | - KRW | -100.0% |
| 2020 Q3 | 110.00 KRW | 128.8% |
| 2020 Q2 | -382.00 KRW | -244.14% |
| 2020 Q1 | -111.00 KRW | 0.0% |
| 2020 FY | - KRW | -2.37% |
| 2019 FY | - KRW | -312.25% |
| 2019 Q4 | - KRW | 100.0% |
| 2019 Q3 | -55.00 KRW | -184.62% |
| 2019 Q2 | 65.00 KRW | 166.91% |
| 2019 Q1 | -97.15 KRW | 0.0% |
| 2018 Q3 | -152.00 KRW | 8.43% |
| 2018 Q4 | - KRW | 100.0% |
| 2018 Q1 | -34.00 KRW | 0.0% |
| 2018 Q2 | -166.00 KRW | -388.24% |
| 2018 FY | - KRW | -300.0% |
| 2017 Q1 | 84.00 KRW | 0.0% |
| 2017 Q3 | 48.00 KRW | 217.07% |
| 2017 Q2 | -41.00 KRW | -148.81% |
| 2017 Q4 | - KRW | -100.0% |
| 2017 FY | - KRW | 14.0% |
| 2016 Q3 | 13.64 KRW | 127.28% |
| 2016 Q4 | - KRW | -100.0% |
| 2016 Q2 | -50.00 KRW | -132.26% |
| 2016 Q1 | 155.00 KRW | 0.0% |
| 2016 FY | - KRW | 655.56% |
| 2015 Q2 | -58.00 KRW | -56.76% |
| 2015 FY | - KRW | 95.87% |
| 2015 Q3 | 88.00 KRW | 251.72% |
| 2015 Q4 | - KRW | -100.0% |
| 2015 Q1 | -37.00 KRW | 0.0% |
| 2014 FY | - KRW | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| HLB Co., Ltd. | -1559.61 KRW | 81.282% |
| iNtRON Biotechnology, Inc. | -292.11 KRW | 0.062% |
| BINEX Co., Ltd. | 151.04 KRW | 293.28% |
| Bioneer Corporation | -410.19 KRW | 28.831% |
| MEDIPOST Co., Ltd. | 287.00 KRW | 201.718% |
| CrystalGenomics, Inc. | -661.00 KRW | 55.835% |
| Helixmith Co., Ltd | -1543.76 KRW | 81.09% |
| Chabiotech Co.,Ltd. | -149.80 KRW | -94.88% |
| Medy-Tox Inc. | 1456.65 KRW | 120.041% |
| Peptron, Inc. | -773.61 KRW | 62.264% |
| Amicogen, Inc. | -583.58 KRW | 49.976% |
| Genexine, Inc. | -1652.14 KRW | 82.33% |
| HLB Therapeutics Co.,Ltd. | -32.12 KRW | -808.873% |
| LegoChem Biosciences, Inc. | -2595.00 KRW | 88.75% |
| ALTEOGEN Inc. | -65.27 KRW | -347.265% |
| PharmaResearch Co., Ltd. | 7502.00 KRW | 103.891% |
| SillaJen, Inc. | -179.98 KRW | -62.201% |
| JETEMA, Co., Ltd. | 783.21 KRW | 137.274% |
| OliX Pharmaceuticals,Inc | -1323.81 KRW | 77.948% |
| Genomictree Inc. | -391.00 KRW | 25.338% |
| MedPacto, Inc. | -1664.87 KRW | 82.465% |
| D&D Pharmatech | 409.19 KRW | 171.343% |
| EASY BIO,Inc. | 455.00 KRW | 164.16% |
| GI Innovation, Inc. | -1285.69 KRW | 77.294% |